Blog
RSS FeedPosted by Michael Wonder on 31 Oct 2019
NICE terminates another two assessments for cancer medicines
30 October 2019 - One medicine is from Janssen; the other is from Eli Lilly. ...
Posted by Michael Wonder on 29 Oct 2019
NHS bill for US drugs 'could soar under post-Brexit trade deal'
28 October 2019 - Dispatches investigation finds 'drug pricing' has been discussed in six initial meetings between trade officials from the ...
Posted by Michael Wonder on 29 Oct 2019
UK officials discussed NHS at ‘secret’ meetings with US drug companies as part of trade talks
29 October 2019 - Envoys sidestep ban on discussing drug prices by referring to controversial subject ‘valuing innovation’. ...
Posted by Michael Wonder on 24 Oct 2019
NHSE signs ‘definitive’ agreement for Vertex CF drugs
24 October 2019 - NHS England has announced a definitive agreement with Vertex Pharmaceuticals to make all three of their ...
Posted by Michael Wonder on 23 Oct 2019
Cystic fibrosis: NHS patients in England to get life-transforming drugs 'within weeks'
23 October 2019 - Orkambi and Symkevi have been shown to radically the improve lung function of sufferers - but were ...
Posted by Michael Wonder on 22 Oct 2019
Evolution or revolution: the latest review of NICE methods
22 October 2019 - The UK’s NICE doesn’t stand still, having seen many changes during its 20 year existence. ...
Posted by Michael Wonder on 18 Oct 2019
NICE ‘ok’ for Bayer’s Xarelto
18 October 2019 - NICE has published the final appraisal determination for Xarelto (rivaroxaban). ...
Posted by Michael Wonder on 11 Oct 2019
Another treatment option for ovarian cancer approved for the Cancer Drugs Fund
11 October 2019 - An ovarian cancer treatment, designed to help maintain the effects of chemotherapy, has been approved by NICE ...
Posted by Michael Wonder on 10 Oct 2019
Biosimilars in the UK: where are we now and where does the NHS want to go?
9 October 2019 - The UK health service has well over a decade’s experience of dealing with biosimilars, but the ...
Posted by Michael Wonder on 10 Oct 2019
Elmiron bags draft NICE approval
10 October 2019 - NICE has published a draft final appraisal regarding Elmiron (pentosan polysulfate sodium) for bladder pain syndrome. ...
Posted by Michael Wonder on 09 Oct 2019
Scottish government readies ports to mitigate Brexit supply disruptions
9 October 2019 - Likely’ disruption to the supply of medicines and radiopharmaceuticals. ...
Posted by Michael Wonder on 05 Oct 2019
Drug pricing: Could Labour’s “radical” plan work?
4 October 2019 - A necessary reform or a threat to research? ...
Posted by Michael Wonder on 04 Oct 2019
Medicines that cannot be parallel exported from the UK
3 October 2019 - Sets out medicines that cannot be parallel exported from the UK because they are needed for UK ...
Posted by Michael Wonder on 03 Oct 2019
Drug firms 'colluded' to overcharge NHS by up to 1,800%
3 October 2019 - Three drug manufactures broke competition law by colluding to illegally boost the price of a vital ...
Posted by Michael Wonder on 03 Oct 2019
ABPI details Brexit plans at PIPA conference
3 October 2019 - The Association of the British Pharmaceutical Industry announced its latest Brexit contingency plans at the PIPA ...